SCOPUS 정보 검색 플랫폼

Volumn 9, Issue , 2013, Pages 1730-1736

Synthesis and quantitative structure-activity relationship study of substituted imidazophosphor ester based tetrazolo[1,5-b]pyridazines as antinociceptive/anti-inflammatory agents

(3) Abdou, Wafaa M a Ganoub, Neven A a Sabry, Eman a

a NATIONAL RESEARCH CENTRE (Egypt)

Author keywords

Antinociceptive anti inflammatory agents; Imidazophosphor esters; Phosphonyl carbanions; Ring closure; Tetrazolo 1,5 b pyridazine

Indexed keywords

EID: 84885051803 PISSN: None EISSN: 18605397 Source Type: Journal
DOI: 10.3762/bjoc.9.199 Document Type: Article

Times cited : (16)

References (35)

1
- 0007450106
- Non-steroidal anti-inflammatory drugs
- 3rd ed.; Foye, W. O., Ed.; LEA & Febiger: Philadelphia, London
- Hamor, G.H. Non-steroidal anti-inflammatory drugs. In Principles of Medicinal Chemistry, 3rd ed.; Foye, W. O., Ed.; LEA & Febiger: Philadelphia, London, 1989; pp 503-530.
- (1989) Principles of Medicinal Chemistry , pp. 503-530
- Hamor, G.H.¹

2
- 34249650109
- Synthesis and biological activity of new anti-inflammatory compounds containing the 1,4-benzodioxine and/or pyrrole system
- DOI 10.1016/j.bmc.2007.04.050, PII S0968089607003781
- Harrak, K.; Rossel, G.; Daidone, G.; Plescia, S.; Schillaci, D.; Pujol, M. D. Bioorg. Med. Chem. 2007, 15, 4876-4890. doi:10.1016/j.bmc.2007.04.050 (Pubitemid 46836837)
- (2007) Bioorganic and Medicinal Chemistry , vol.15 , Issue.14 , pp. 4876-4890
- Harrak, Y.¹ Rosell, G.² Daidone, G.³ Plescia, S.⁴ Schillaci, D.⁵ Pujol, M.D.⁶

3
- 0034075728
- Novel antiarthritic agents with 1,2-isothiazolidine-1-,1-dioxide (γ- sultam) skeleton: Cytokine suppressive dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase
- DOI 10.1021/jm9906015
- Inagaki, M.; Tsuri, T.; Jyoyama, H.; Ono, T.; Yamada, K.; Kobayashi, M.; Hori, Y.; Arimura, A.; Yasui, K.; Ohno, K.; Kakudo, S.; Koizumi, K.; Suzuki, R.; Kato, M.; Kawai, S.; Matsumoto, S. J. Med. Chem. 2000, 43, 2040-2048. doi:10.1021/jm9906015 (Pubitemid 30340943)
- (2000) Journal of Medicinal Chemistry , vol.43 , Issue.10 , pp. 2040-2048
- Inagaki, M.¹ Tsuri, T.² Jyoyama, H.³ Ono, T.⁴ Yamada, K.⁵ Kobayashi, M.⁶ Hori, Y.⁷ Arimura, A.⁸ Yasui, K.⁹ Ohno, K.¹⁰ Kakudo, S.¹¹ Koizumi, K.¹² Suzuki, R.¹³ Kato, M.¹⁴ Kawai, S.¹⁵ Matsumoto, S.¹⁶

4
- 0037364161
- The development of COX2 inhibitors
- DOI 10.1038/nrd1034
- Flower, R. J. Nat. Rev. Drug Discovery 2003, 2, 179-191. doi:10.1038/nrd1034 (Pubitemid 37361663)
- (2003) Nature Reviews Drug Discovery , vol.2 , Issue.3 , pp. 179-191
- Flower, R.J.¹

5
- 0035246513
- Cyclooxygenase inhibitors - Current status and future prospects
- DOI 10.1016/S0223-5234(01)01197-7, PII S0223523401011977
- Dannhardt, G.; Kiefer, W. Eur. J. Med. Chem. 2001, 36, 109-126. doi:10.1016/S0223-5234(01)01197-7 (Pubitemid 32304514)
- (2001) European Journal of Medicinal Chemistry , vol.36 , Issue.2 , pp. 109-126
- Dannhardt, G.¹ Kiefer, W.²

6
- 0002731507
- Leukotrienes: Biosynthetic pathways, release and receptor-mediated actions with relevance to disease states
- Gallin, J. L; Snyderman, R., Eds.; Lippicort Williams & Wilkins: Philadelphia
- Penrose, J. F.; Austen, K. F.; Lam, B. K. Leukotrienes: Biosynthetic Pathways, Release and Receptor-Mediated Actions with Relevance to Disease States. In Inflammation Basic Principles and Clinical Correlates; Gallin, J. L; Snyderman, R., Eds.; Lippicort Williams & Wilkins: Philadelphia, 1999; pp 361-372.
- (1999) Inflammation Basic Principles and Clinical Correlates , pp. 361-372
- Penrose, J.F.¹ Austen, K.F.² Lam, B.K.³

7
- 0031777185
- doi:10.1146/annurev.pharmtox.38.1.97
- Vane, J. R.; Bakhle, Y. S.; Botting, R. M. Annu. Rev. Pharmacol. Toxicol. 1998, 38, 97-120. doi:10.1146/annurev.pharmtox.38.1.97
- (1998) Annu. Rev. Pharmacol. Toxicol. , vol.38 , pp. 97-120
- Vane, J.R.¹ Bakhle, Y.S.² Botting, R.M.³

8
- 0031808163
- Dirig, D. M.; Isakson, P. C; Yaksh, T. L. J. Pharmacol. Exp. Ther. 1998, 285, 1031-1038.
- (1998) J. Pharmacol. Exp. Ther. , vol.285 , pp. 1031-1038
- Dirig, D.M.¹ Isakson, P.C.² Yaksh, T.L.³

9
- 0038147318
- Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs
- DOI 10.1136/ard.62.6.501
- Martel-Pelletier, J.; Lajeunesse, D.; Reboul, P.; Pelletier, J.-P. Ann. Rheum. Dis. 2003, 62, 501-509. doi:10.1136/ard.62.6.501 (Pubitemid 36606279)
- (2003) Annals of the Rheumatic Diseases , vol.62 , Issue.6 , pp. 501-509
- Martel-Pelletier, J.¹ Lajeunesse, D.² Reboul, P.³ Pelletier, J.-P.⁴

10
- 78650517810
- doi:10.1016/j.ejmech.2010.10.035
- Pontiki, E.; Hadjipavlou-Litina, D.; Litinas, K.; Nicolotti, O.; Carotti, A. Eur. J. Med. Chem. 2011, 46, 191-200. doi:10.1016/j.ejmech.2010.10.035
- (2011) Eur. J. Med. Chem. , vol.46 , pp. 191-200
- Pontiki, E.¹ Hadjipavlou-Litina, D.² Litinas, K.³ Nicolotti, O.⁴ Carotti, A.⁵

11
- 77954313236
- doi:10.1016/j.bmcl.2010.05.022
- Roussaki, M.; Kontogiorgis, C. A.; Hadjipavlou-Litina, D.; Hamilakis, S.; Detsi, A. Bioorg. Med. Chem. Lett. 2010, 20, 3889-3892. doi:10.1016/j.bmcl. 2010.05.022
- (2010) Bioorg. Med. Chem. Lett. , vol.20 , pp. 3889-3892
- Roussaki, M.¹ Kontogiorgis, C.A.² Hadjipavlou-Litina, D.³ Hamilakis, S.⁴ Detsi, A.⁵

12
- 77951959254
- doi:10.1111/j.1747-0285.2010.00963.x
- Rajić, Z.; Hadjipavlou-Litina, D.; Pontiki, E.; Kralj, M.; Šuman, L; Zorc, B. Chem. Biol. Drug Des. 2010, 75, 641-652. doi:10.1111/j.1747-0285.2010.00963.x
- (2010) Chem. Biol. Drug Des. , vol.75 , pp. 641-652
- Rajić, Z.¹ Hadjipavlou-Litina, D.² Pontiki, E.³ Kralj, M.⁴ Šuman, L.⁵ Zorc, B.⁶

13
- 84868597341
- doi:10.1002/ardp.201200142
- Abdou, W. M.; Barghash, R. F.; Bekheit, M. S. Arch. Pharm. 2012, 345, 884-895. doi:10.1002/ardp.201200142
- (2012) Arch. Pharm. , vol.345 , pp. 884-895
- Abdou, W.M.¹ Barghash, R.F.² Bekheit, M.S.³

14
- 79958104561
- doi:10.1007/s00706-011-0492-8
- Abdou, W. M.; Barghash, R. F.; Bekheit, M. S. Monatsh. Chem. 2011, 142, 649-656. doi:10.1007/s00706-011-0492-8
- (2011) Monatsh. Chem. , vol.142 , pp. 649-656
- Abdou, W.M.¹ Barghash, R.F.² Bekheit, M.S.³

15
- 84859206446
- doi:10.1080/00397911.2010.551170
- Abdou, W. M.; Khidre, R. E.; Barghash, R. F. Synth. Commun. 2012, 42, 1967-1978. doi:10.1080/00397911.2010.551170
- (2012) Synth. Commun. , vol.42 , pp. 1967-1978
- Abdou, W.M.¹ Khidre, R.E.² Barghash, R.F.³

16
- 84872062727
- doi:10.1039/c2ra22769j
- Abdou, W. M.; Barghash, R. F.; Bekheit, M. S. RSCAdv. 2013, 3, 1528-1540. doi:10.1039/c2ra22769j
- (2013) RSCAdv , vol.3 , pp. 1528-1540
- Abdou, W.M.¹ Barghash, R.F.² Bekheit, M.S.³

17
- 81855221807
- doi:10.1002/jhet.743
- Sediek, A. A.; Shaddy, A. A.; Abdou, W. M. J. Heterocycl. Chem. 2011, 48, 1258-1263. doi:10.1002/jhet.743
- (2011) J. Heterocycl. Chem. , vol.48 , pp. 1258-1263
- Sediek, A.A.¹ Shaddy, A.A.² Abdou, W.M.³

18
- 60149087594
- doi:10.1016/j.ejmech.2008.03.032
- Abdou, W. M.; Khidre, M. D.; Khidre, R. E. Eur. J. Med. Chem. 2009, 44, 526-532. doi:10.1016/j.ejmech.2008.03.032
- (2009) Eur. J. Med. Chem. , vol.44 , pp. 526-532
- Abdou, W.M.¹ Khidre, M.D.² Khidre, R.E.³

19
- 61349083551
- doi:10.3184/030823409X393646
- Abdou, W. M.; Shaddy, A. A.; Sediek, A. A. J. Chem. Res. 2009, 8-13. doi:10.3184/030823409X393646
- (2009) J. Chem. Res. , pp. 8-13
- Abdou, W.M.¹ Shaddy, A.A.² Sediek, A.A.³

20
- 44549088821
- doi:10.1007/s00706-007-0806-z
- Abdou, W. M.; Sediek, A. A.; Khidre, M. D. Monatsh. Chem. 2008, 139, 617-623. doi:10.1007/s00706-007-0806-z
- (2008) Monatsh. Chem. , vol.139 , pp. 617-623
- Abdou, W.M.¹ Sediek, A.A.² Khidre, M.D.³

21
- 84873806734
- doi:10.1002/jhet.968
- Abdou, W. M.; Khidre, R. E.; Shaddy, A. A. J. Heterocycl. Chem. 2013, 50, 33-41. doi:10.1002/jhet.968
- (2013) J. Heterocycl. Chem. , vol.50 , pp. 33-41
- Abdou, W.M.¹ Khidre, R.E.² Shaddy, A.A.³

22
- 84856351713
- doi:10.1002/ardp.201100080
- Abdou, W. M.; Khidre, R. E.; Kamel, A. A. Arch. Pharm. 2012, 345, 123-136. doi:10.1002/ardp.201100080
- (2012) Arch. Pharm. , vol.345 , pp. 123-136
- Abdou, W.M.¹ Khidre, R.E.² Kamel, A.A.³

23
- 84885078809
- Bhaskar, V. H.; Mohite, P. B. J. Optoelectron. Biomed. Mater. 2011, 3, 7-16.
- (2011) Optoelectron. Biomed. Mater. , vol.3 , pp. 7-16
- Bhaskar, V.H.¹ Mohite, P.B.J.²

24
- 0035105126
- 5-disubstituted-3-methyl-1H-pyrazolo[3,4-c]pyridazines
- DOI 10.1016/S0968-0896(00)00285-6, PII S0968089600002856
- Tewari, A. K.; Mishra, A. Bioorg. Med. Chem. 2001, 9, 715-718. doi:10.1016/S0968-0896(00)00285-6 (Pubitemid 32208590)
- (2001) Bioorganic and Medicinal Chemistry , vol.9 , Issue.3 , pp. 715-718
- Tewari, A.K.¹ Mishra, A.²

25
- 84885055078
- U.S. Patent US5219845, June 15
- Salari, H.; Bittman, R. Phosphonates as anti-inflammation agents. U.S. Patent US5219845, June 15, 1993.
- (1993) Phosphonates as Anti-inflammation Agents
- Salari, H.¹ Bittman, R.²

26
- 33846097671
- Potent anti-inflammatory activity of 3-aminovinylphosphonates as inhibitors of reactive oxygen intermediates, nitric oxides generation, and tumor necrosis factor-alpha release
- DOI 10.1016/j.ejphar.2006.10.041, PII S0014299906012076
- Al Quntar, A. A. A.; Gallily, R.; Katzavian, G.; Srebnik, M. Eur. J. Pharmacol. 2007, 556, 9-13. doi:10.1016/j.ejphar.2006.10.041 (Pubitemid 46073992)
- (2007) European Journal of Pharmacology , vol.556 , Issue.1-3 , pp. 9-13
- Quntar, A.A.A.A.¹ Gallily, R.² Katzavian, G.³ Srebnik, M.⁴

27
- 84986701218
- doi:10.1002/jlac.1991199101210
- Deep, A.; Sterk, H.; Kappe, T. Liebigs Ann. Chem. 1991, 1225-1227. doi:10.1002/jlac.1991199101210
- (1991) Liebigs Ann. Chem. , pp. 1225-1227
- Deep, A.¹ Sterk, H.² Kappe, T.³

28
- 0002349767
- doi:10.1055/s-1973-22145
- Tisler, M. Synthesis 1973, 123-136. doi:10.1055/s-1973-22145
- (1973) Synthesis , pp. 123-136
- Tisler, M.¹

29
- 78149361433
- doi:10.1007/s10593-010-0579-x
- Kategaonkar, A. H.; Sapkal, S. B.; Madje, B. R.; Shingate, B. B.; Shingare, M. S. Chem. Heterocycl. Compd. 2010, 46, 754-758. doi:10.1007/s10593- 010-0579-x
- (2010) Chem. Heterocycl. Compd. , vol.46 , pp. 754-758
- Kategaonkar, A.H.¹ Sapkal, S.B.² Madje, B.R.³ Shingate, B.B.⁴ Shingare, M.S.⁵

30
- 0032762398
- doi:10.1002/jhet.5570360504
- Shin, M.-S.; Kang, Y.-J.; Chung, H.-A.; Park, J.-W.; Kweon, D.-H.; Lee, W. S.; Yoon, Y.-J.; Kim, S.-K. J. Heterocycl. Chem. 1999, 36, 1135-1142. doi:10.1002/jhet.5570360504
- (1999) J. Heterocycl. Chem. , vol.36 , pp. 1135-1142
- Shin, M.-S.¹ Kang, Y.-J.² Chung, H.-A.³ Park, J.-W.⁴ Kweon, D.-H.⁵ Lee, W.S.⁶ Yoon, Y.-J.⁷ Kim, S.-K.⁸

31
- 0031319350
- doi:10.1080/10426509708033698
- He, L.-N.; Cai, F.; Chen, R.-Y.; Zhou, J. Phosphorus, Sulfur Silicon Relat. Elem. 1997, 130, 65-71. doi:10.1080/10426509708033698
- (1997) Phosphorus, Sulfur Silicon Relat. Elem. , vol.130 , pp. 65-71
- He, L.-N.¹ Cai, F.² Chen, R.-Y.³ Zhou, J.⁴

32
- 9144255536
- Effects of Bisphosphonates on the Growth of Entamoeba histolytica and Plasmodium Species in Vitro and in Vivo
- DOI 10.1021/jm030084x
- Ghosh, S.; Chan, J. M. W.; Lea, C. R.; Meints, G. A.; Lewis, J. C; Tovian, Z. S.; Flessner, R. M.; Loftus, T. C; Bruchhaus, I.; Kendrick, H.; Croft, S. L.; Kemp, R. G.; Kobayashi, S.; Nozaki, T.; Oldfield, E. J. Med. Chem. 2004, 47, 175-187. doi:10.1021/jm030084x (Pubitemid 38040501)
- (2004) Journal of Medicinal Chemistry , vol.47 , Issue.1 , pp. 175-187
- Ghosh, S.¹ Chan, J.M.W.² Lea, C.R.³ Meints, G.A.⁴ Lewis, J.C.⁵ Tovian, Z.S.⁶ Flessner, R.M.⁷ Loftus, T.C.⁸ Bruchhaus, I.⁹ Kendrick, H.¹⁰ Croft, S.L.¹¹ Kemp, R.G.¹² Kobayashi, S.¹³ Nozaki, T.¹⁴ Oldfield, E.¹⁵

33
- 33744762777
- Bisphosphonates: From bench to bedside
- DOI 10.1196/annals.1346.041
- Russell, R. G. G. Ann. N. Y. Acad. Sci. 2006, 1068, 367-401. doi:10.1196/annals.1346.041 (Pubitemid 43824169)
- (2006) Annals of the New York Academy of Sciences , vol.1068 , Issue.1 , pp. 367-401
- Russell, R.G.G.¹

34
- 0000782975
- Okun, R.; Liddon, S. C; Lasagna, L. J. Pharmacol. Exp. Ther. 1963, 139, 107-109.
- (1963) Pharmacol. Exp. Ther. , vol.139 , pp. 107-109
- Okun, R.¹ Liddon, S.C.² Lasagna, L.J.³

35
- 67249094291
- Winter, C. A.; Risley, E. A.; Nuss, G. W. Proc. Soc. Exp. Biol. Med. 1962, 111, 544-547.
- (1962) Proc. Soc. Exp. Biol. Med. , vol.111 , pp. 544-547
- Winter, C.A.¹ Risley, E.A.² Nuss, G.W.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.